IPXL Share Price

Open 16.05 Change Price %
High 16.52 1 Day 0.25 1.57
Low 15.88 1 Week -0.30 -1.82
Close 16.20 1 Month 0.95 6.23
Volume 1008188 1 Year -12.93 -44.39
52 Week High 32.20
52 Week Low 7.75
IPXL Important Levels
Resistance 2 16.79
Resistance 1 16.55
Pivot 16.20
Support 1 15.85
Support 2 15.61
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
ASTI 0.00 0.00%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
QQQ 140.02 1.44%
DCTH 0.20 -9.09%
More..
NASDAQ USA Top Gainers Stocks
SPEX 1.91 70.54%
CPSL 0.09 50.00%
LOCM 0.09 50.00%
QKLS 0.15 36.36%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SPNC 38.35 26.15%
SNTA 0.34 25.93%
OTT 2.39 25.13%
THTI 0.20 17.65%
More..
NASDAQ USA Top Losers Stocks
CAFI 0.00 -100.00%
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

Impax Laboratories, Inc. (NASDAQ: IPXL)

IPXL Technical Analysis 1.5
As on 28th Jun 2017 IPXL Share Price closed @ 16.20 and we RECOMMEND Sell for LONG-TERM with Stoploss of 16.87 & Buy for SHORT-TERM with Stoploss of 14.93 we also expect STOCK to react on Following IMPORTANT LEVELS.
IPXL Target for June
1st Target up-side 18.06
2nd Target up-side 20.02
3rd Target up-side 21.99
1st Target down-side 12.44
2nd Target down-side 10.48
3rd Target down-side 8.51
IPXL Other Details
Segment EQ
Market Capital 1367854592.00
Sector Healthcare
Industry Drug Manufacturers - Major
Offical website http://www.impaxlabs.com
IPXL Address
IPXL
30831 Huntwood Avenue
Hayward, CA 94544
United States
Phone: 510-476-2000
Fax: 510-471-3200
IPXL Latest News
Interactive Technical Analysis Chart Impax Laboratories, Inc. ( IPXL NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Impax Laboratories, Inc.
IPXL Business Profile
Impax Laboratories Inc. is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and marketing of bioequivalent pharmaceutical products, referred to as generics, in addition to the development and marketing of branded products. The Company operates in two segments: Global Pharmaceuticals Division (Global Division) and the Impax Pharmaceuticals Division (Impax Division). The Global Division concentrates its efforts on the development, manufacture, sale and distribution of the Company's generic products, which are the pharmaceutical and therapeutic equivalents of brand-name drug products and are usually marketed under their established drug names. The Impax Division is engaged in the development of brand pharmaceutical products for the treatment of central nervous system (CNS) disorders. The Impax Division is also engaged in the sale and distribution of Zomig (zolmitriptan) products.